| Symbol | MAZE |
|---|---|
| Name | MAZE THERAPEUTICS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Address | 171 OYSTER POINT BOULEVARD,SUITE 300, SAN FRANCISCO, California, 94080, United States |
| Telephone | 6508505070 |
| Fax | — |
| — | |
| Website | https://www.mazetx.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001842295 |
| Description | Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity. We are advancing a pipeline using our Compass platform, which allows us to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process we refer to as variant functionalization. Our Compass platform has been purpose-built to inform all phases of our drug discovery and development process through clinical trial design. We are currently advancing two wholly owned lead programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease. We initiated a Phase 2 trial of our lead drug candidate, MZE829, in November 2024. Additional info from NASDAQ: |
Bernstein Harold 🟡 adjusted position in 14.6K shares (1 derivative) of Maze Therapeutics, Inc. (MAZE) at $30.34 Transaction Date: Jul 01, 2026 | Filing ID: 000025
Read moreColoma Jason V 🔴 sold 34.5K shares of Maze Therapeutics, Inc. (MAZE) at $30.44 ($1.0M) Transaction Date: Jul 01, 2026 | Filing ID: 000014
Read more📋 Coloma Jason V (Officer) plans to sell 35K shares of Maze Therapeutics, Inc. (at $29.98 each, total $1.0M) Filed: Jul 01, 2026 | ID: 000748
Read moreColoma Jason V 🔴 sold 27.9K shares of Maze Therapeutics, Inc. (MAZE) at $26.05 Transaction Date: Jun 22, 2026 | Filing ID: 000012
Read moreSPIEGELMAN DANIEL K 🟢 acquired 18.0K shares (1 derivative) of Maze Therapeutics, Inc. (MAZE) at $23.58 Transaction Date: Jun 08, 2026 | Filing ID: 000004
Read moreSCHELLER RICHARD H 🟢 acquired 18.0K shares (1 derivative) of Maze Therapeutics, Inc. (MAZE) at $23.58 Transaction Date: Jun 08, 2026 | Filing ID: 000002
Read moreLim Jonathan E 🟢 acquired 18.0K shares (1 derivative) of Maze Therapeutics, Inc. (MAZE) at $23.58 Transaction Date: Jun 08, 2026 | Filing ID: 000002
Read moreHoppenot Herve 🟢 acquired 18.0K shares (1 derivative) of Maze Therapeutics, Inc. (MAZE) at $23.58 Transaction Date: Jun 08, 2026 | Filing ID: 000007
Read moreHOMCY CHARLES J 🟢 acquired 18.0K shares (1 derivative) of Maze Therapeutics, Inc. (MAZE) at $23.58 Transaction Date: Jun 08, 2026 | Filing ID: 000004
Read moreAndrews Nancy C 🟢 acquired 18.0K shares (1 derivative) of Maze Therapeutics, Inc. (MAZE) at $23.58 Transaction Date: Jun 08, 2026 | Filing ID: 000002
Read more